Azidothymidine in the Treatment of AIDS

This publication has 12 references indexed in Scilit:

• Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome.
  Journal of Clinical Investigation, 1987
• The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Developmental Therapeutics and the Acquired Immunodeficiency Syndrome
  Annals of Internal Medicine, 1987
• AZIDOTHYMIDINE NEUROTOXICITY
  The Lancet, 1986
• Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
  Proceedings of the National Academy of Sciences, 1986
• ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1986
• 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
  Proceedings of the National Academy of Sciences, 1985
• Scientific problems in clinical scales, as demonstrated in the karnofsky index of performance status
  Journal of Chronic Diseases, 1979
• The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma
  Cancer, 1948